Publications

Found 5 results
Filters: Author is Z. Yang  [Clear All Filters]
2016
Z. Yang, Li, X., Zhang, N., Zhang, Y. N., Jiang, H. W., Gao, J., Kuai, B. K., Ding, Y. L., Huang, X. Q., Yang, Z., Li, X., Zhang, N., Zhang, Y. N., Jiang, H. W., Gao, J., Kuai, B. K., Ding, Y. L., and Huang, X. Q., “Detection of quantitative trait loci for kernel oil and protein concentration in a B73 and Zheng58 maize cross”, vol. 15, p. -, 2016.
Z. Yang, Li, X., Zhang, N., Zhang, Y. N., Jiang, H. W., Gao, J., Kuai, B. K., Ding, Y. L., Huang, X. Q., Yang, Z., Li, X., Zhang, N., Zhang, Y. N., Jiang, H. W., Gao, J., Kuai, B. K., Ding, Y. L., and Huang, X. Q., “Detection of quantitative trait loci for kernel oil and protein concentration in a B73 and Zheng58 maize cross”, vol. 15, p. -, 2016.
2015
J. Xi, Yue, J., and Yang, Z., “Expression profiles of retinoic acid synthetases ALDH1As and metabolic enzymes CYP26s in adult and embryonic zebrafish (Danio rerio)”, vol. 14, pp. 3948-3956, 2015.
2014
X. H. Pei, Yang, Z., Lv, X. Q., and Li, H. X., “Genetic variation in ERCC1 and XPF genes and breast cancer risk”, vol. 13, pp. 2259-2267, 2014.
2011
Z. Yang, Ke, Z. F., Zeng, C., Wang, Z., Shi, H. J., and Wang, L. T., “Mutation characteristics in type I collagen genes in Chinese patients with osteogenesis imperfecta”, vol. 10, pp. 177-185, 2011.
Barnes AM, Chang W, Morello R, Cabral WA, et al. (2006). Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N. Engl. J. Med. 355: 2757-2764. http://dx.doi.org/10.1056/NEJMoa063804 PMid:17192541   Benusiene E and Kucinskas V (2003). COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta. J. Appl. Genet. 44: 95-102. PMid:12590186   Bhattacharyya N and Banerjee D (1999). Transcriptional regulatory sequences within the first intron of the chicken apolipoprotein AI (apoAI) gene. Gene 234: 371-380. http://dx.doi.org/10.1016/S0378-1119(99)00183-3   Chessler SD, Wallis GA and Byers PH (1993). Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. J. Biol. Chem. 268: 18218-18225. PMid:8349697   Clement JQ and Wilkinson MF (2000). Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB. J. Mol. Biol. 299: 1179-1191. http://dx.doi.org/10.1006/jmbi.2000.3745 PMid:10873444   Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, et al. (2002). Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J. Biol. Chem. 277: 4223-4231. http://dx.doi.org/10.1074/jbc.M110709200 PMid:11704682   Engel J and Prockop DJ (1991). The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Annu. Rev. Biophys. Biophys. Chem. 20: 137-152. http://dx.doi.org/10.1146/annurev.bb.20.060191.001033 PMid:1867713   Forlino A and Marini JC (2000). Osteogenesis imperfecta: prospects for molecular therapeutics. Mol. Genet. Metab. 71: 225-232. http://dx.doi.org/10.1006/mgme.2000.3039 PMid:11001814   Glorieux FH, Rauch F, Plotkin H, Ward L, et al. (2000). Type V osteogenesis imperfecta: a new form of brittle bone disease. J. Bone Miner. Res. 15: 1650-1658. http://dx.doi.org/10.1359/jbmr.2000.15.9.1650 PMid:10976985   Hartikka H, Kuurila K, Korkko J, Kaitila I, et al. (2004). Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients. Hum. Mutat. 24: 147-154. http://dx.doi.org/10.1002/humu.20071 PMid:15241796   Kuivaniemi H, Tromp G and Prockop DJ (1997). Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum. Mutat. 9: 300-315. http://dx.doi.org/10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9   Mattick JS (1994). Introns: evolution and function. Curr. Opin. Genet. Dev. 4: 823-831. http://dx.doi.org/10.1016/0959-437X(94)90066-3   Morello R, Bertin TK, Chen Y, Hicks J, et al. (2006). CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127: 291-304. http://dx.doi.org/10.1016/j.cell.2006.08.039 PMid:17055431   Pace JM, Chitayat D, Atkinson M, Wilcox WR, et al. (2002). A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases. J. Med. Genet. 39: 23-29. http://dx.doi.org/10.1136/jmg.39.1.23 PMid:11826020 PMCid:1734955   Pepin M, Atkinson M, Starman BJ and Byers PH (1997). Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: a review of biochemical and molecular studies completed in 129 pregnancies. Prenat. Diagn. 17: 559- 570. http://dx.doi.org/10.1002/(SICI)1097-0223(199706)17:6<559::AID-PD111>3.0.CO;2-G   Pollitt R, McMahon R, Nunn J, Bamford R, et al. (2006). Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum. Mutat. 27: 716. http://dx.doi.org/10.1002/humu.9430 PMid:16786509   Sykes B (1993). Linkage analysis in dominantly inherited osteogenesis imperfecta. Am. J. Med. Genet. 45: 212-216. http://dx.doi.org/10.1002/ajmg.1320450212 PMid:8456805   Venturi G, Tedeschi E, Mottes M, Valli M, et al. (2006). Osteogenesis imperfecta: clinical, biochemical and molecular findings. Clin. Genet. 70: 131-139. http://dx.doi.org/10.1111/j.1399-0004.2006.00646.x PMid:16879195   Vuorio E and de Crombrugghe B (1990). The family of collagen genes. Annu. Rev. Biochem. 59: 837-872. http://dx.doi.org/10.1146/annurev.bi.59.070190.004201 PMid:2197991